Qi Shen – Trademark Portfolio

Entity Type: 01

Qi Shen owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as SQHT, BIDABID, and DR. SHOESERT. Of these, 4 are registered. The portfolio spans 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 25 (Clothing). Headquartered in New York, NY.

450 W 42nd St, Apt 41D

New York, NY 10036

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SQHT
SQHT
Registered 2025
BIDABID
BIDABID
Registered 2025
BIDABID
BIDABID
Registered 2025
DR. FOOT
DR. FOOT
Abandoned 2023
DR. FOOT
DR. FOOT
Abandoned 2023

Trademark Classifications

Qi Shen's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

25
Clothing (2 filings)

Clothing, footwear, headgear

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Qi Shen have?

Qi Shen has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does Qi Shen file in?

Qi Shen files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

What are Qi Shen's most well-known trademarks?

Qi Shen's registered trademark portfolio includes well-known marks such as SQHT, BIDABID, and DR. SHOESERT. These are among 4 currently registered trademarks in the portfolio.

What is Qi Shen's trademark registration success rate?

Qi Shen has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.